TNF and inflammatory bowel disease: We now report that eNAMPT and eNAPRT levels are elevated in IBD patients in both blood and faces, that their levels correlate with pathological score and with high sensitivity C reactive protein (hsCRP), and, most importantly, confirm that they represent predictive biomarkers for response to anti-TNF treatment.